Skip to content

Inspection Record

GlaxoSmithKline Biologicals SA — FDA 483 Findings

US FDAInspected 2019-06-24Published 2026-10-26 5 findingsOther quality systemAseptic processing and sterility assuranceEquipment and facilityLaboratory and QC controlsQuality unit oversight

Inspectors Debra M. Emerson · Susan Jackson · Leslie Wagner and 1 moreThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The following corrective actions were found deficient: a.

2Aseptic processing and sterility assurance

Failure to thoroughly investigate the presence of) _,,, in the Water for Injection (WFI) | os where sterile bukh is manufactured.

3Equipment and facility

The following equipment maintenance issues were on observed on June 7, 2019 in the) a | ww manufacturing building: a.

4Laboratory and QC controls

Laboratory controls do not include the establishment of scientifically sound and appropriate specifications designed to assure that in-process materials conform to appropriate standards of purity.

5Quality unit oversight

There is a lack of documentation approved by the Quality Unit to support operating outside of your routine operations.

A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

GlaxoSmithKline Biologicals SA findings history — including this company's other documentsAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.